Kristin Neff, MS

Kristin Neff is the Vice President of Clinical Operations at GentiBio. Kristin is an experienced Clinical Operations leader with a deep commitment to pursuing treatments for autoimmune diseases and is passionate about improving the lives of people living with Type 1 diabetes. Kristin was the VP of Clinical Operations at Provention Bio where she led the pivotal teplizumab program in patients with recently diagnosed type 1 diabetes. Kristin continued to work in type 1 diabetes at Sanofi after their acquisition of Provention Bio. Previously, Kristin worked at Anokion on clinical development programs for celiac disease and multiple sclerosis, and at ImmusanT, InVivo Therapeutics and Taris Biomedical. Kristin has extensive experience in all phases of clinical development, and in building clinical operations teams and managing out-sourced programs, as well as experience in strategic planning and project management. Kristin has an M.S. degree in Biomedical Engineering from Boston University and a B.S. in Electrical Engineering from University of Massachusetts. In addition to getting clinical studies done, Kristin enjoys reading, movies, baking for friends and family, and traveling.